The California Health Care Foundation's CHCF Innovation Fund announced this week that it has invested a total of slightly more than $1 million in Madison, Wisconsin-based Asthmapolis, which offers a FDA-cleared inhaler sensor and app for people with asthma, COPD, or cystic fibrosis. CHCF has made two investments in Asthmapolis over the years but the bulk of the $1 million makes up its most recent...
A WellPoint health plan in Florida, called Amerigroup Florida, announced that it will offer Asthmapolis' FDA-cleared mobile health device and service to its members with asthma.
Asthmapolis' device is a sensor that sits atop (most) inhalers used by patients who have asthma or COPD. The sensor transmits data to a companion app on the user’s mobile phone every time the inhaler is used. The app can...
